Stephen Lyle
Operating Partner @ Stage 1 Ventures
Waltham, United States
Stephen Lyle is a startup investor at Stage 1 Ventures in Waltham. Dr. Lyle is the Director of KEW Group’s Molecular Diagnostics Lab and is the former Lab Director of Predictive Biosciences, and former Medical Director of Catalyst Oncology, Inc. He has served as a consultant for a number of biotech companies including Pavonis/Beauty Medicines, Switch Biotech AG, Andorra, Inc./Living Proof, Dyax Corp.,Diagnocure, Inc., Arresto Biosciences, Merrimack Pharmaceuticals and Bioserve.Dr. Lyle holds an appointment as Associate Professor of Cancer Biology and Pathology, UMass Medical School and is the Co-Director of the UMass Cancer Center Tissue Bank. He has held NIH and private foundation grants to study adult stem cell biology, cancer stem cells and skin biology. He has received a multiple awards, grants and fellowships from The National Institutes of Health, William Keck Foundation, The Ellison Foundation, Society of Investigative Dermatology, Dermatology Foundation, Burroughs Wellcome Trust, and The March of Dimes. He is a member of The American Association for Cancer Research, The Society of Investigative Dermatology and is a Fellow of the College of American Pathologists. He is an author on over 75 research publications, book chapters and reviews.Prior to his clinical fellowship training in the Harvard Combined Dermatopathology Program, he was a resident and surgical pathology fellow at the Hospital of the University of Pennsylvania, where he received the prestigious HT Enterline Fellowship Award. While at the University of Pennsylvania, he also completed a research post-doctoral fellowship in the lab of George Cotsarelis, M.D. in the Department of Dermatology. During this time Dr. Lyle made the breakthrough discovery of the location and characteristics of adult epithelial stem cells in human skin that launched his research career.Dr. Lyle is a graduate of The Pritzker School of Medicine/University of Chicago where he completed his M.D. and Ph.D. in Biochemistry and Molecular Biology. He also graduated with honors from the University of Chicago in the combined B.A. / M.S. program in Biochemistry
Last updated:
For AI agents: llms.txt
About Stage 1 Ventures
Stage 1 Ventures is an early stage venture capital firm that is seeking to build partnerships with great entrepreneurs that are flexible and who want to build meaningful companies. They want to assist you with their global network of relationships as well as provide the capital you need to fuel the growth of your company.Their market focus todayis in Mobile, the Executable Internet or Software as a Service (SaaS) , IPTV and Internet Video, Pay-For-Performance Marketing and Advertising, and Security.
Stage 1 Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Bill O’Connell
Operating Partner
|
|||
David H Buckley
Operating Partner
|
|||
David William Baum
Founder, Partner & Managing Director
|
|||
Joesph Pianelli
Operating Partner
|
|||
|
Stephen Lyle
Operating Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
